JPRN-UMIN000019084尚未招募未知
A randomized, double-blinded, placebo-controlled, crossover study of 5-aminolevulinic acid in the prevention of migraine - Examination of the 5-aminolevulinic acid for the migraine
Department of neurosurgery, Osaka Medical college0 个研究点目标入组 50 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Individuals taking drugs or supplements influence to the migraine attacks. 2. Severe liver or renal impairment 3. Allergy to 5-aminolevulinic acid. 4. Severe systemic disorders, which need to medication. 5. Previous stroke or transient ischemic attack 6. Pregnancy or breastfeeding, including women trying to conceive 7. Porphyria and photosensitivity 8. History of alcohol or analgesic or psychotropic drug abuse 9. Those who already have entered another clinical trials.
研究者
相似试验
进行中（未招募）
不适用
Investigating the effectiveness and safety of gelatin tannate and tyndallized acid lactic bacteria in adult patients with chronic diarrhoea with dysbiosisISRCTN63068134oventure S.L.190
招募中
1 期
‘A clinical trial to test the safety and immune responses from the BG505 SOSIP.664 gp140 HIV vaccine in development’.PACTR202006565880683IAVI60
已完成
不适用
A randomized, double-blinded, placebo-controlled, single centre, phase I study of the safety of escalating single intravenous doses of NI-0801 in healthy volunteers.psoriasis10003816NL-OMON33532ovImmune S.A.30
尚未招募
2 期
The CANBACK trial, to determine the efficacy of oral cannabidiol, when compared to placebo, as an adjunct for the treatment of acute non-traumatic low back pain.Back painACTRN12618000487213Dr Bronwyn Bebee100
招募中
不适用
A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV-1 envelope protein BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted in healthy, HIV-uninfected adultsAIDSHIV10047438NL-OMON54857International AIDS Vaccine Initiative (IAVI)18